Earnings digests and industry comparisons for Japan's biggest listed companies.
640 reports(page 1 of 54)
Otsuka said VOYXACT cut the two-year risk of kidney decline or failure by 97.1% in a 510-patient phase 3 trial. It completed a staged U.S. filing for full approval after accelerated approval in November 2025, and kept its 2026 forecast unchanged.
Olympus said the FDA issued an import alert for some products made at three group facilities in Japan, restricting U.S. imports until further notice. It sees no additional impact on fiscal 2027 results and kept its forecast unchanged.
Koito will liquidate its Hubei subsidiary after a Sept. 28, 2026, board decision, citing EV growth and weaker Japanese automaker sales. The move aims to improve China operations, with little impact expected on FY2027 earnings.
Tsugami raised its first-half fiscal 2027 forecast, lifting operating profit 29.2% to ¥25.2 billion and profit attributable to owners 36.7% to ¥12.3 billion. It increased the interim dividend to ¥61 from ¥49 a share, with full-year guidance due Nov. 12.
Mitsubishi Electric will move its distribution controls business into a new company and sell 51% to ABB’s Japan unit for a planned ¥82.4 billion. The venture is due to launch Oct. 1, 2027, with Mitsubishi Electric retaining 49%.
Relo Group will acquire a 90.0% voting stake in Singapore-based ATIV Medical for an estimated ¥1.68 billion, including fees. The deal is scheduled to close Oct. 30, 2026, linking expatriate support with Southeast Asian healthcare.
Mitsubishi Electric will jointly run its auto unit with Foxconn, which will invest ¥115 billion for half of the business in October 2027. It expects about ¥100 billion in impairment losses for the year ending March 2027, with its earnings outlook due Oct. 30.
Kajima withdrew its Supreme Court appeal and review petition challenging a Fair Trade Commission order over JR Central's Chuo Shinkansen project. Related cases end, measures are complete and its full-year forecast is unchanged.
Koei Tecmo on Oct. 19 raised its forecast for the six months through September 2026, lifting ordinary profit to ¥25bn, up 108.3%. Sales and other profit forecasts also increased, but the full-year outlook was unchanged.
Tokyo Steel raised its full-year non-consolidated earnings forecast for the fiscal year ending March 2027 on October 16, 2026. The company now projects net sales of ¥326.0 billion and an operating profit of ¥1.0 billion, swinging from a previously forecasted ¥4.0 billion loss. Successful product price hikes and lower scrap steel costs drove the recovery, though earnings remain an upward revision with a year-on-year profit decline.
Mitsubishi Estate will convert MEC Kikan Logistics 2 SPC into a wholly owned subsidiary via a ¥15 billion investment on Oct. 29, 2026. The move aims to boost its logistics base, with minor earnings impact for FY3/2027.
